Kronox Lab Sciences Ltd (KRONOX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039273,
    "name": "Kronox Lab",
    "stock_name": "Kronox Lab",
    "full_name": "Kronox Lab Sciences Ltd",
    "name_url": "stocks-analysis/kronox-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "128.10",
    "chg": 5.65,
    "chgp": "4.61%",
    "dir": 1,
    "prev_price": "122.45",
    "mcapval": "463.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544187,
    "symbol": "KRONOX",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE0ATZ01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "44.43 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kronox-lab-10039273-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kronox Lab Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kronox-lab-downgraded-to-sell-by-marketsmojo-amid-valuation-and-technical-concerns-3738110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KronoxLab_mojoScore_3738110.png",
        "date": "2025-12-01 10:09:02",
        "description": "Kronox Lab, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid subdued stock performance and valuation concerns, highlighting the challenges faced by the company in maintaining investor confidence."
      },
      {
        "title": "Why is Kronox Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kronox-lab-fallingrising-3727203",
        "imagepath": "",
        "date": "2025-11-25 01:50:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>Kronox Lab’s recent price action has been notably weak compared to benchmark indices. Over the past week, the stock declined by 5.60%, significantly underperforming the Sensex, which remained nearly flat with a marginal 0.06% gain. This underperformance extends over longer periods as well, with the stock down 6.94% in the last month while the Sensex gained 0.82%. Year-to-date figures reveal a stark contrast, with Kronox Lab falling 29.28% against the Sensex’s 8.65% rise. Even on a one-year basis, the stock is down 15.41%, whereas the benchmark index has appreciated by 7.31%. These figures highlight sustained weakness in the stock relative to the broader market.</p>\n<p><strong>Intraday Trading Dynamics and Moving Averages</strong></p..."
      },
      {
        "title": "How has been the historical performance of Kronox Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kronox-lab-3695818",
        "imagepath": "",
        "date": "2025-11-13 00:41:22",
        "description": "Answer:\nThe historical performance of Kronox Lab shows a consistent growth in net sales and profitability over the past four years.\n\nBreakdown:\nKronox Lab's net sales have increased from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25, reflecting a positive growth trend. The total operating income followed a similar trajectory, rising from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated significant growth, moving from 20.79 Cr in Mar'22 to 35.65 Cr in Mar'25, with an operating profit margin of 33.06% in the latest fiscal year. Profit before tax increased from 18.36 Cr in Mar'22 to 34.27 Cr in Mar'25, while profit after tax rose from 13.63 Cr to 25.47 Cr during the same period, resulting in a PAT margin of 25.42% in Mar'25. On the balance sheet, total assets grew from 56.46 Cr in Mar'22 to 98.43 Cr in Mar'25, with total liabilities increasing from 56.46 Cr to 98...."
      },
      {
        "title": "Are Kronox Lab latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-kronox-lab-latest-results-good-or-bad-3693272",
        "imagepath": "",
        "date": "2025-11-12 19:36:04",
        "description": "Kronox Lab Sciences has reported its financial results for Q2 FY26, showcasing a company that is managing operational challenges with a focus on margin preservation, despite limited revenue growth. The net profit for the quarter was ₹6.68 crores, reflecting a sequential increase of 6.37% and a year-on-year rise of 3.24%. Revenue for the same period reached ₹25.53 crores, which represents a 5.10% increase from the previous quarter and a modest 2.70% gain compared to the same quarter last year. \n\nThe operating margin, excluding other income, improved to 33.84%, marking the highest level in the last seven quarters, which indicates effective cost management and operational efficiency. The profit after tax (PAT) margin was reported at 26.17%, also among the strongest in recent history for the company. \n\nHowever, the overall revenue growth remains subdued, with a half-yearly performance showing a slight decline o..."
      },
      {
        "title": "Kronox Lab Sciences Q2 FY26: Margin Strength Masks Muted Growth Amid Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/kronox-lab-sciences-q2-fy26-margin-strength-masks-muted-growth-amid-valuation-concerns-3692869",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KronoxLabScienc_quaterlyResult_3692869.png",
        "date": "2025-11-12 09:56:56",
        "description": "Kronox Lab Sciences Ltd., a micro-cap specialty chemicals manufacturer, reported a modest quarter in Q2 FY26, with net profit rising to ₹6.68 crores—a sequential increase of 6.37% quarter-on-quarter (QoQ) and 3.24% year-on-year (YoY). With a market capitalisation of ₹546.91 crores, the Ahmedabad-based company continues to demonstrate operational resilience through strong margins, yet faces headwinds from tepid revenue growth and an increasingly bearish market sentiment. The stock closed at ₹147.40 on November 12, 2025, down 0.84% on the day, reflecting investor caution following the results announcement."
      },
      {
        "title": "Why is Kronox Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kronox-lab-fallingrising-3687442",
        "imagepath": "",
        "date": "2025-11-11 00:25:46",
        "description": "As of 10-Nov, Kronox Lab Sciences Ltd is experiencing a decline in its stock price, currently at Rs 143.45, which reflects a decrease of Rs 2.6 or 1.78%. The stock has underperformed its sector by 1.02% today and reached an intraday low of Rs 143.05, indicating a downward trend. Over the past week, the stock has decreased by 2.08%, and its performance over the last month shows a significant decline of 5.63%. Year-to-date, the stock has fallen by 27.95%, while its one-year return is down by 15.69%. Additionally, Kronox Lab is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent bearish trend. There is also a notable decrease in investor participation, with delivery volume falling by 2.3% compared to the 5-day average, indicating waning interest in the stock.\n\nIn the broader market context, the Sensex has shown a relatively stable performance, with a slight de..."
      }
    ],
    "total": 140,
    "sid": "10039273",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kronox-lab-sciences-10039273"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Closure of Trading Window for the Quarter and Nine Months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Closure of Trading Window for the Quarter and Nine Months ending December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kronox Lab Sciences Ltd has declared <strong>5%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kronox Lab Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges

2025-12-01 10:09:02

Kronox Lab, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid subdued stock performance and valuation concerns, highlighting the challenges faced by the company in maintaining investor confidence.

Why is Kronox Lab falling/rising?

2025-11-25 01:50:28

Recent Price Performance and Market Context Kronox Lab’s recent price action has been notably weak compared to benchmark indices. Over the past week, the stock declined by 5.60%, significantly underperforming the Sensex, which remained nearly flat with a marginal 0.06% gain. This underperformance extends over longer periods as well, with the stock down 6.94% in the last month while the Sensex gained 0.82%. Year-to-date figures reveal a stark contrast, with Kronox Lab falling 29.28% against the Sensex’s 8.65% rise. Even on a one-year basis, the stock is down 15.41%, whereas the benchmark index has appreciated by 7.31%. These figures highlight sustained weakness in the stock relative to the broader market. Intraday Trading Dynamics and Moving Averages</p...

How has been the historical performance of Kronox Lab?

2025-11-13 00:41:22

Answer: The historical performance of Kronox Lab shows a consistent growth in net sales and profitability over the past four years. Breakdown: Kronox Lab's net sales have increased from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25, reflecting a positive growth trend. The total operating income followed a similar trajectory, rising from 82.25 Cr in Mar'22 to 100.19 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated significant growth, moving from 20.79 Cr in Mar'22 to 35.65 Cr in Mar'25, with an operating profit margin of 33.06% in the latest fiscal year. Profit before tax increased from 18.36 Cr in Mar'22 to 34.27 Cr in Mar'25, while profit after tax rose from 13.63 Cr to 25.47 Cr during the same period, resulting in a PAT margin of 25.42% in Mar'25. On the balance sheet, total assets grew from 56.46 Cr in Mar'22 to 98.43 Cr in Mar'25, with total liabilities increasing from 56.46 Cr to 98....

Are Kronox Lab latest results good or bad?

2025-11-12 19:36:04

Kronox Lab Sciences has reported its financial results for Q2 FY26, showcasing a company that is managing operational challenges with a focus on margin preservation, despite limited revenue growth. The net profit for the quarter was ₹6.68 crores, reflecting a sequential increase of 6.37% and a year-on-year rise of 3.24%. Revenue for the same period reached ₹25.53 crores, which represents a 5.10% increase from the previous quarter and a modest 2.70% gain compared to the same quarter last year. The operating margin, excluding other income, improved to 33.84%, marking the highest level in the last seven quarters, which indicates effective cost management and operational efficiency. The profit after tax (PAT) margin was reported at 26.17%, also among the strongest in recent history for the company. However, the overall revenue growth remains subdued, with a half-yearly performance showing a slight decline o...

Kronox Lab Sciences Q2 FY26: Margin Strength Masks Muted Growth Amid Valuation Concerns

2025-11-12 09:56:56

Kronox Lab Sciences Ltd., a micro-cap specialty chemicals manufacturer, reported a modest quarter in Q2 FY26, with net profit rising to ₹6.68 crores—a sequential increase of 6.37% quarter-on-quarter (QoQ) and 3.24% year-on-year (YoY). With a market capitalisation of ₹546.91 crores, the Ahmedabad-based company continues to demonstrate operational resilience through strong margins, yet faces headwinds from tepid revenue growth and an increasingly bearish market sentiment. The stock closed at ₹147.40 on November 12, 2025, down 0.84% on the day, reflecting investor caution following the results announcement.

Why is Kronox Lab falling/rising?

2025-11-11 00:25:46

As of 10-Nov, Kronox Lab Sciences Ltd is experiencing a decline in its stock price, currently at Rs 143.45, which reflects a decrease of Rs 2.6 or 1.78%. The stock has underperformed its sector by 1.02% today and reached an intraday low of Rs 143.05, indicating a downward trend. Over the past week, the stock has decreased by 2.08%, and its performance over the last month shows a significant decline of 5.63%. Year-to-date, the stock has fallen by 27.95%, while its one-year return is down by 15.69%. Additionally, Kronox Lab is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent bearish trend. There is also a notable decrease in investor participation, with delivery volume falling by 2.3% compared to the 5-day average, indicating waning interest in the stock. In the broader market context, the Sensex has shown a relatively stable performance, with a slight de...

View All News